YOR392W Antibody

What is YOR392W and why is it studied in yeast research?

YOR392W is a protein-coding gene in Saccharomyces cerevisiae (baker's yeast) with the UniProt accession number Q08915 . This protein is of interest in yeast research due to its potential role in cellular processes. The YOR392W antibody is specifically designed to detect this protein in S. cerevisiae strain ATCC 204508/S288c, making it valuable for studying protein expression patterns, localization, and interactions in this model organism. Understanding YOR392W contributes to our broader knowledge of cellular functions in eukaryotic systems, as many yeast proteins have homologs in higher organisms including humans.

What applications has the YOR392W antibody been validated for?

The YOR392W antibody has been specifically tested and validated for Enzyme-Linked Immunosorbent Assay (ELISA) and Western Blot (WB) applications, with particular emphasis on ensuring proper identification of the antigen . These applications allow researchers to:

• Quantify YOR392W protein levels using ELISA

• Determine the molecular weight and expression levels of YOR392W in protein extracts via Western Blot

• Compare YOR392W expression across different experimental conditions

When designing experiments, researchers should consider that this antibody has been specifically validated with the S. cerevisiae strain ATCC 204508/S288c, which may affect cross-reactivity with other yeast strains.

What are the optimal storage and handling conditions for YOR392W antibody?

For maximum stability and activity retention, the YOR392W antibody should be stored at either -20°C or -80°C immediately upon receipt . The antibody should not undergo repeated freeze-thaw cycles as this can degrade the protein structure and reduce antibody efficiency. The antibody is provided in a liquid formulation containing preservative (0.03% Proclin 300) and stabilizers (50% Glycerol, 0.01M PBS, pH 7.4) .

For routine use:

• Aliquot the antibody into smaller volumes upon first thaw

• Store working dilutions at 4°C for up to one week

• Return stock solutions to -20°C or -80°C for long-term storage

• Avoid exposure to light and contamination with microorganisms

How should sample preparation be optimized for YOR392W detection?

Optimal sample preparation is crucial for successful detection of YOR392W in yeast cells. Based on general antibody methodologies and yeast protein extraction techniques:

• For cell lysate preparation:

  • Harvest yeast cells during the appropriate growth phase

  • Disrupt cell walls using glass beads or enzymatic methods

  • Extract proteins in a buffer containing protease inhibitors to prevent degradation

  • Clear lysates by centrifugation to remove cell debris

• For Western blot applications:

  • Denature proteins in sample buffer containing SDS and a reducing agent

  • Load adequate protein amounts (typically 20-50 μg total protein)

  • Include a loading control to normalize YOR392W detection across samples

Similar to considerations for antibody titration in other systems, reducing antibody concentration may improve signal-to-noise ratio while maintaining detection sensitivity .

What optimization strategies improve signal-to-noise ratio with YOR392W antibody?

Optimizing the signal-to-noise ratio is crucial for obtaining reliable results with the YOR392W antibody. Drawing from research on antibody optimization techniques:

• Concentration titration:

  • Perform a systematic dilution series (e.g., 1:500, 1:1000, 1:2000, 1:4000)

  • Most antibodies show optimal performance between 0.625-2.5 μg/mL, with reduced background at lower concentrations

  • Antibodies used at high concentrations (>2.5 μg/mL) often show minimal response to fourfold titration reduction

• Blocking optimization:

  • Test different blocking agents (BSA, milk, commercial blockers)

  • Optimize blocking time and temperature

  • Consider using the blocking agent in antibody diluent

• Washing protocol refinement:

  • Increase number and duration of washes

  • Test different detergent concentrations in wash buffers

  • Use automated washers for consistent results

Recent research on antibody optimization shows that "reducing concentration of antibodies targeting highly expressed epitopes can be further reduced without affecting resolution of positive and negative cells, even when these antibodies are already used within their linear concentration range" .

How can researchers validate YOR392W antibody specificity?

Validating antibody specificity is essential to ensure experimental results accurately reflect YOR392W biology. A comprehensive validation approach includes:

• Genetic controls:

  • Test the antibody in YOR392W knockout strains (should show no signal)

  • Use YOR392W overexpression strains as positive controls

• Peptide competition assays:

  • Pre-incubate the antibody with purified YOR392W protein or peptide

  • A specific antibody will show reduced or eliminated signal

• Cross-reactivity assessment:

  • Test the antibody against related yeast proteins

  • Evaluate potential detection of homologous proteins in other yeast species

• Western blot profile analysis:

  • Confirm detection of a single band at the expected molecular weight

  • Multiple bands may indicate cross-reactivity or protein modification

What considerations are important for detecting YOR392W post-translational modifications?

Detection of post-translational modifications (PTMs) on YOR392W requires special considerations:

• Modification-specific antibody selection:

  • For acetylation studies, use anti-acetyl-lysine antibodies alongside YOR392W antibody

  • Consider that "identification of non-histone acetylation targets in Saccharomyces" may require specialized approaches

• Sample preparation adaptations:

  • Include deacetylase inhibitors (e.g., TSA, nicotinamide) in lysis buffers when studying acetylation

  • Use phosphatase inhibitors when investigating phosphorylation

  • Optimize extraction methods to preserve labile modifications

• Detection strategy:

  • Perform immunoprecipitation with YOR392W antibody followed by Western blot with modification-specific antibodies

  • Consider mass spectrometry validation of modifications

What are common causes of weak or absent YOR392W antibody signal?

When experiencing weak or absent signal with YOR392W antibody, consider these potential issues and solutions:

• Protein expression variables:

  • YOR392W may be expressed at low levels under standard conditions

  • Test different growth phases and stress conditions to induce expression

  • Consider concentrating proteins through immunoprecipitation before detection

• Technical optimization opportunities:

  • Increase antibody concentration or incubation time

  • Enhance signal using more sensitive detection methods (chemiluminescence vs. colorimetric)

  • Optimize blocking conditions to reduce background without diminishing signal

• Sample preparation refinements:

  • Ensure complete cell lysis and protein extraction

  • Verify protein transfer efficiency in Western blots

  • Test fresh antibody aliquots to rule out degradation

Research on antibody signals shows that "background signal can account for a major fraction of total sequencing and is primarily derived from antibodies used at high concentrations" , suggesting careful titration may help optimize signal-to-noise ratio.

How should YOR392W antibody be validated in chromatin immunoprecipitation (ChIP) experiments?

While the YOR392W antibody's product information specifically mentions validation for ELISA and Western blot , researchers interested in ChIP applications should perform additional validation:

• ChIP-specific antibody qualification:

  • Test antibody recognition of native (non-denatured) YOR392W protein

  • Optimize crosslinking conditions specific to YOR392W

  • Validate antibody binding to fixed chromatin preparations

• ChIP-qPCR verification:

  • Design primers for genomic regions where YOR392W is expected to bind

  • Include negative control regions where binding is not expected

  • Compare enrichment between specific and control regions

• Specificity controls:

  • Perform ChIP in YOR392W deletion strains

  • Include isotype control antibodies in parallel experiments

  • Consider epitope-tagged YOR392W strains for validation

Drawing from approaches in antibody research, researchers should note that "high background and limited response to titration when used above 2.5 μg/mL" can affect results , suggesting careful optimization of antibody concentration for ChIP applications.

What considerations apply when using YOR392W antibody in co-immunoprecipitation studies?

For researchers using YOR392W antibody in co-immunoprecipitation (co-IP) to study protein-protein interactions:

• Buffer optimization for complex preservation:

  • Test different lysis buffers with varying detergent types and concentrations

  • Consider non-denaturing conditions to maintain native protein complexes

  • Include protease inhibitors to prevent degradation during lengthy procedures

• Antibody coupling strategies:

  • Directly couple antibody to beads to avoid IgG contamination in eluates

  • Test different antibody:bead ratios to optimize pulldown efficiency

  • Consider crosslinking antibody to beads to prevent antibody leaching

• Validation of interactions:

  • Perform reciprocal co-IPs when possible

  • Include negative controls (non-specific IgG, unrelated proteins)

  • Confirm interactions using orthogonal methods (yeast two-hybrid, proximity labeling)

When designing co-IP experiments, consider that this antibody is polyclonal , which may provide advantages for capturing different conformations of YOR392W but might introduce variability between antibody lots.

How can YOR392W antibody be incorporated into multimodal single-cell analysis?

Integrating YOR392W antibody into advanced single-cell analysis techniques requires special considerations:

• Antibody conjugation options:

  • Consider oligonucleotide conjugation for CITE-seq applications

  • Optimize antibody concentration as "oligo-conjugated antibodies show high background and limited response to titration when used above 2.5 μg/mL"

  • For optimal results, conduct titration experiments as "antibodies can be further diluted, despite being at their linear concentration range, without affecting the identification of epitope-positive cells"

• Multiplexing considerations:

  • When combining with other antibodies, balance concentrations to avoid sequencing read bias

  • Note that "by simply reducing the concentration of the five antibodies used at 10 μg/mL, [researchers] gained 17% more reads for the remaining antibodies"

  • Plan panel design to allow adequate signal for all targets

• Sample preparation adaptations:

  • Optimize cell fixation protocols to preserve epitope accessibility

  • Consider cell number during staining as "reducing the number of cells present during staining" can counteract effects of reduced staining volume

What approaches enable studying temporal dynamics of YOR392W expression?

To investigate temporal dynamics of YOR392W expression and localization:

• Time-course experimental design:

  • Sample cells at regular intervals during growth phases

  • Synchronize yeast cultures to normalize cell cycle position

  • Quantify YOR392W protein levels by Western blot at each timepoint

• Live-cell imaging considerations:

  • Generate fluorescently-tagged YOR392W constructs for direct visualization

  • Verify tagged construct functionality through complementation assays

  • Optimize imaging parameters to reduce phototoxicity during extended imaging

• Inducible expression systems:

  • Place YOR392W under control of regulatable promoters

  • Monitor protein dynamics following induction or repression

  • Correlate protein levels with phenotypic outcomes

When designing temporal studies, remember that this antibody is specific to Saccharomyces cerevisiae strain ATCC 204508/S288c , so strain differences should be considered when interpreting results.

How does YOR392W antibody research contribute to understanding conserved cellular pathways?

YOR392W research using specific antibodies contributes to broader understanding of conserved pathways:

• Evolutionary conservation analysis:

  • Compare YOR392W sequence and function with homologs in other species

  • Identify conserved domains that may be targets for antibody development

  • Consider that "while there's great diversity amongst people's collection of antibodies, there are some types that most people likely share" , suggesting evolutionary conservation principles may apply to YOR392W

• Pathway mapping approaches:

  • Use YOR392W antibody in combination with antibodies against known pathway components

  • Perform co-localization studies to identify spatial relationships

  • Investigate changes in YOR392W expression or modification in response to pathway perturbation

• Translational research implications:

  • Identify human proteins with similar functions to YOR392W

  • Investigate whether findings in yeast translate to mammalian systems

  • Consider how YOR392W studies might inform understanding of human disease mechanisms

How might computational approaches enhance YOR392W antibody development and applications?

Recent advances in computational biology offer opportunities to enhance antibody research:

• AI-assisted antibody design:

  • Machine learning approaches have demonstrated "critical capabilities and advantages over purely experimental techniques" in protein research

  • Models like MAGE (Monoclonal Antibody GEnerator) represent "a first-in-class model capable of designing" target-specific antibodies

  • Similar approaches could potentially optimize YOR392W antibody specificity and affinity

• Structural prediction integration:

  • Use protein structure prediction tools to identify accessible epitopes on YOR392W

  • Model antibody-antigen interactions to optimize binding

  • Guide antibody engineering efforts through in silico analysis

• Data integration platforms:

  • Combine antibody-based experimental data with -omics datasets

  • Develop computational workflows to normalize and integrate multi-source data

  • Build predictive models of YOR392W function based on integrated analyses

Current research indicates that "AI-based approaches have been developed to optimize existing antibodies and generate novel antibody sequences" , suggesting future applications for YOR392W research.

What quality control metrics should be applied to YOR392W antibody batches?

To ensure experimental reproducibility across antibody batches:

• Standardized validation assays:

  • Western blot against reference yeast lysates

  • ELISA titration curves against purified YOR392W protein

  • Immunofluorescence with standardized fixation protocols

• Quantitative performance metrics:

  • Signal-to-noise ratio in standard assays

  • Limit of detection determination

  • Batch-to-batch variation coefficient calculation

• Documentation requirements:

  • Production method verification (antigen affinity purification)

  • Lot-specific validation data

  • Application-specific recommended dilutions

Quality control is particularly important as this antibody is "Made-to-order (14-16 weeks)" , suggesting potential for batch variation that should be systematically assessed.